SRT Sartorius Aktiengesellschaft

XETRA · DE · Healthcare · Medical Instruments & Supplies · sartorius.com

206.50EUR+2.23%Mkt Cap: 15.16B $P/E: 71.38Today

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometr…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap15.16B USD

Enterprise Value20.56B USD

Revenue (TTM)3.89B USD

Gross Profit1.78B USD

Net Income (TTM)168.37M USD

Revenue/Share51.24 EUR

Last Price206.50 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees14.3K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINDE0007165631

Valuation

P/E (Trailing)71.38

P/E (Forward)31.09

PEG0.75

EV/EBITDA20.16

EV/Revenue5.28

P/S3.90

P/B5.17

EPS (TTM)2.83

EPS (Forward)6.51

52W Range

158.2086% of range214.50

52W High214.50 EUR

52W Low158.20 EUR

Profitability

Gross Margin46.26%

Oper. Margin18.00%

EBITDA Margin26.20%

Profit Margin4.38%

ROE5.72%

ROA1.59%

Growth

Revenue Growth3.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF909.78M USD

CapEx (TTM)480.33M USD

FCF Margin9.07%

FCF Yield2.33%

Net Debt4.09B USD

Net Debt/EBITDA4.01

Balance Sheet

Debt/Equity1.58

Current Ratio1.14

Quick Ratio0.48

Book Value/Sh39.20 EUR

Cash/Share4.22 EUR

Dividends

Fwd Div Rate0.73 EUR

Trail. Div Rate0.74 EUR

Div. Yield0.36%

5Y Avg Yield0.35%

Payout Ratio25.80%

Ex-Div DateMar 27, 2026

Pay Date—

Splits

Last Split4:1

Split DateJun 13, 2016

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)251.08 EUR

Upside (mean)+21.6%

Target Range68.75 EUR – 445.00 EUR

68.75+21.6% to mean445.00

# Analysts9

Ownership

Shares Out.34.24M

Float27.45M

Insiders87.07%

Institutions1.40%

Technical

SMA 50192.11 (+7.5%)

SMA 200185.62 (+11.3%)

Beta1.47

S&P 52W Chg14.58%

Avg Vol (30d)2.67K

Avg Vol (10d)4.04K

Technical Indicators

RSI (14)55.4

MACD3.5616

MACD Signal3.6134

MACD Hist.-0.0518

BB Upper215.30 EUR

BB Middle197.69 EUR

BB Lower180.08 EUR

BB Width17.82%

ATR (14)6.438 EUR

Vol Ratio (20d)1.27x